Cabot M C, Welsh C J
Cancer Res. 1981 Dec;41(12 Pt 1):4910-5.
Human promyelocytic leukemia cells (HL-60) undergo differentiation when treated with the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). As the primary target for TPA action is membranes, studies were undertaken to determine whether phorbol ester exposure would influence fatty acid metabolism in these cells. In cells incubated with labeled fatty acids for 1 hr, the percentage of distribution of lipid radioactivity is highest in the phospholipid fraction of control cultures, whereas in TPA-supplemented cells, substantially more label is associated with triacylglycerols. The specific activity of phospholipids and triacylglycerols was lower in treated than in control cells; however, the amount of cellular triacylglycerols increased 3.2-fold (lipid per mg protein). The increase in the amount of cellular phospholipids in TPA-treated cells is not as pronounced (approximately 50% above control), and this only occurs at higher concentrations of TPA. At early times after TPA exposure, there is no stimulation of the cellular uptake of labeled fatty acids; however, differentiating cells (24 to 48 hr of TPA), when incubated with label, contained more radioactivity than did control cultures. Cells treated with TPA for 48 hr show a marked decrease in the conversion of [1-14C]stearic acid to monoenoic product (22% of control); this decrease is dose dependent and occurs within 24 to 48 hr of treatment. Although the phospholipid fatty acid composition of differentiating cells was similar to control cells, acyl groups of triacylglycerols isolated from treated cells showed a marked decrease in the percentage of unsaturates. These data provide evidence which demonstrates that TPA treatment of HL-60 cells has a profound effect on fatty acid metabolism. The lack of an effect of TPA on fatty acid metabolism after short-term exposure to the promoter suggests that the modifications observed may be the result of cellular differentiation rather than a direct effect exerted by the presence of TPA in the culture media.
人早幼粒细胞白血病细胞(HL - 60)在用肿瘤促进剂12 - O - 十四酰佛波醇 - 13 - 乙酸酯(TPA)处理时会发生分化。由于TPA作用的主要靶点是细胞膜,因此开展了相关研究以确定佛波酯暴露是否会影响这些细胞中的脂肪酸代谢。在用标记脂肪酸孵育1小时的细胞中,脂质放射性分布的百分比在对照培养物的磷脂部分中最高,而在添加TPA的细胞中,与三酰甘油相关的标记物要多得多。处理后的细胞中磷脂和三酰甘油的比活性低于对照细胞;然而,细胞三酰甘油的量增加了3.2倍(每毫克蛋白质中的脂质)。TPA处理的细胞中细胞磷脂量的增加并不明显(比对照高约50%),且仅在较高浓度的TPA下才会出现。在TPA暴露后的早期,细胞对标记脂肪酸的摄取没有受到刺激;然而,分化细胞(TPA处理24至48小时)在与标记物一起孵育时,所含的放射性比对照培养物更多。用TPA处理48小时的细胞显示[1 - 14C]硬脂酸向单烯酸产物的转化显著降低(为对照的22%);这种降低是剂量依赖性的,且在处理24至48小时内发生。尽管分化细胞的磷脂脂肪酸组成与对照细胞相似,但从处理细胞中分离出的三酰甘油的酰基显示不饱和物的百分比显著降低。这些数据提供了证据,表明TPA处理HL - 60细胞对脂肪酸代谢有深远影响。短期暴露于该促进剂后TPA对脂肪酸代谢没有影响,这表明观察到的变化可能是细胞分化的结果,而不是培养基中TPA的存在所产生的直接作用。